Biocon Limited (BIOCON.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Biocon Limited
Sector
Healthcare
Industry
Biotechnology
Employees
16315
First IPO Date
April 07, 2004
Key Executives
| Name | Title | Pay | Year Born |
| Shreehas Pradeep Tambe MTech | CEO, MD & Additional Director | 0 | 1974 |
| Rajesh Shanoy | Company Secretary & Compliance Officer | 5.75M | N/A |
| Kiran Mazumdar Shaw | Founder & Executive Chairperson | 42.28M | 1953 |
| Anuj Goel | Chief Development Officer | 0 | 1965 |
| Mandar S. Ghatnekar | Chief Technology Officer | 0 | N/A |
| Akhilesh Kumar Nand | Head of Governance, Risk & Compliance | 0 | N/A |
| Kedar Narayan Upadhye | Chief Financial Officer | 0 | 1977 |
| Naveen Narayanan | Chief Human Resources Officer | 0 | N/A |
| Paul Vazhayil Thomas | Chief Commercial Officer, U.S. & Portfolio Strategy & Business Dev, Adv mkts of Biosimilars Business | 0 | 1973 |
| Saurabh Paliwal | Head of Investor Relations | 0 | N/A |
| Seema Shah Ahuja | SVP & Global Head Corporate Communications & Corporate Brand Biocon Group | 0 | 1966 |
Description
Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
